178 related articles for article (PubMed ID: 19211248)
21. Synthesis and evaluation of substrate analogues as mechanism-based inhibitors of type II isopentenyl diphosphate isomerase.
Walker JR; Rothman SC; Poulter CD
J Org Chem; 2008 Jan; 73(2):726-9. PubMed ID: 18088143
[TBL] [Abstract][Full Text] [Related]
22. 4,5-Diaryl-3-aminopyrazole derivatives as analogs of Combretastatin A-4: synthesis and biological evaluation.
Liu T; Cui R; Chen J; Zhang J; He Q; Yang B; Hu Y
Arch Pharm (Weinheim); 2011 May; 344(5):279-86. PubMed ID: 21290430
[TBL] [Abstract][Full Text] [Related]
23. N-Phenyl-N'-(2-chloroethyl)urea analogues of combretastatin A-4: Is the N-phenyl-N'-(2-chloroethyl)urea pharmacophore mimicking the trimethoxy phenyl moiety?
Fortin S; Moreau E; Lacroix J; Teulade JC; Patenaude A; C-Gaudreault R
Bioorg Med Chem Lett; 2007 Apr; 17(7):2000-4. PubMed ID: 17291753
[TBL] [Abstract][Full Text] [Related]
24. The concise synthesis of chalcone, indanone and indenone analogues of combretastatin A4.
Kerr DJ; Hamel E; Jung MK; Flynn BL
Bioorg Med Chem; 2007 May; 15(9):3290-8. PubMed ID: 17360188
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of 4/5-hydroxy-2,3-diaryl(substituted)-cyclopent-2-en-1-ones as cis-restricted analogues of combretastatin A-4 as novel anticancer agents.
Gurjar MK; Wakharkar RD; Singh AT; Jaggi M; Borate HB; Shinde PD; Verma R; Rajendran P; Dutt S; Singh G; Sanna VK; Singh MK; Srivastava SK; Mahajan VA; Jadhav VH; Dutta K; Krishnan K; Chaudhary A; Agarwal SK; Mukherjee R; Burman AC
J Med Chem; 2007 Apr; 50(8):1744-53. PubMed ID: 17373779
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis, and biological testing of pyrazoline derivatives of combretastatin-A4.
Johnson M; Younglove B; Lee L; LeBlanc R; Holt H; Hills P; Mackay H; Brown T; Mooberry SL; Lee M
Bioorg Med Chem Lett; 2007 Nov; 17(21):5897-901. PubMed ID: 17827004
[TBL] [Abstract][Full Text] [Related]
27. A new family of quinoline and quinoxaline analogues of combretastatins.
Pérez-Melero C; Maya AB; del Rey B; Peláez R; Caballero E; Medarde M
Bioorg Med Chem Lett; 2004 Jul; 14(14):3771-4. PubMed ID: 15203159
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents.
Ruan BF; Lu X; Tang JF; Wei Y; Wang XL; Zhang YB; Wang LS; Zhu HL
Bioorg Med Chem; 2011 Apr; 19(8):2688-95. PubMed ID: 21440448
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preliminary biological evaluation of new anti-tubulin agents containing different benzoheterocycles.
Romagnoli R; Baraldi PG; Jung MK; Iaconinoto MA; Carrion MD; Remusat V; Preti D; Tabrizi MA; Francesca F; De Clercq E; Balzarini J; Hamel E
Bioorg Med Chem Lett; 2005 Sep; 15(18):4048-52. PubMed ID: 16005627
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis and biological evaluation of novel stilbene-based antitumor agents.
Simoni D; Invidiata FP; Eleopra M; Marchetti P; Rondanin R; Baruchello R; Grisolia G; Tripathi A; Kellogg GE; Durrant D; Lee RM
Bioorg Med Chem; 2009 Jan; 17(2):512-22. PubMed ID: 19117761
[TBL] [Abstract][Full Text] [Related]
31. Domino approach to 2-aroyltrimethoxyindoles as novel heterocyclic combretastatin A4 analogues.
Arthuis M; Pontikis R; Chabot GG; Quentin L; Scherman D; Florent JC
Eur J Med Chem; 2011 Jan; 46(1):95-100. PubMed ID: 21112130
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and antitumor activity of benzils related to combretastatin A-4.
Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
[TBL] [Abstract][Full Text] [Related]
33. Antineoplastic agents. 487. Synthesis and biological evaluation of the antineoplastic agent 3,4-methylenedioxy-5,4'-dimethoxy-3'-amino-Z-stilbene and derived amino acid amides.
Pettit GR; Anderson CR; Herald DL; Jung MK; Lee DJ; Hamel E; Pettit RK
J Med Chem; 2003 Feb; 46(4):525-31. PubMed ID: 12570374
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and biological evaluation of thiophene and benzo[b]thiophene analogs of combretastatin A-4 and isocombretastatin A-4: A comparison between the linkage positions of the 3,4,5-trimethoxystyrene unit.
Do CV; Faouzi A; Barette C; Farce A; Fauvarque MO; Colomb E; Catry L; Berthier-Vergnes O; Haftek M; Barret R; Lomberget T
Bioorg Med Chem Lett; 2016 Jan; 26(1):174-80. PubMed ID: 26602281
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of (3,4,5-trimethoxyphenyl)indol-3-ylmethane derivatives as potential antivascular agents.
Dupeyre G; Chabot GG; Thoret S; Cachet X; Seguin J; Guénard D; Tillequin F; Scherman D; Koch M; Michel S
Bioorg Med Chem; 2006 Jul; 14(13):4410-26. PubMed ID: 16529936
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Characterization, and Bioactivity of the Photoisomerizable Tubulin Polymerization Inhibitor azo-Combretastatin A4.
Engdahl AJ; Torres EA; Lock SE; Engdahl TB; Mertz PS; Streu CN
Org Lett; 2015 Sep; 17(18):4546-9. PubMed ID: 26335519
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of combretastatin A4 analogues on steroidal framework and their anti-breast cancer activity.
Parihar S; Kumar A; Chaturvedi AK; Sachan NK; Luqman S; Changkija B; Manohar M; Prakash O; Chanda D; Khan F; Chanotiya CS; Shanker K; Dwivedi A; Konwar R; Negi AS
J Steroid Biochem Mol Biol; 2013 Sep; 137():332-44. PubMed ID: 23459143
[TBL] [Abstract][Full Text] [Related]
38. Controllable diastereoselective cyclopropanation. Enantioselective synthesis of vinylcyclopropanes via chiral telluronium ylides.
Liao WW; Li K; Tang Y
J Am Chem Soc; 2003 Oct; 125(43):13030-1. PubMed ID: 14570468
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological activity of fluorinated combretastatin analogues.
Alloatti D; Giannini G; Cabri W; Lustrati I; Marzi M; Ciacci A; Gallo G; Tinti MO; Marcellini M; Riccioni T; Guglielmi MB; Carminati P; Pisano C
J Med Chem; 2008 May; 51(9):2708-21. PubMed ID: 18396857
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, evaluation and structural studies of antiproliferative tubulin-targeting azetidin-2-ones.
O'Boyle NM; Greene LM; Bergin O; Fichet JB; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
Bioorg Med Chem; 2011 Apr; 19(7):2306-25. PubMed ID: 21397510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
